No problems, and thanks to you regarding forward capacity as...

No problems, and thanks to you regarding forward capacity as well!
Seems I overlooked production constraints, in favour of the actual technology itself. ( Bloody confirmation bias. ).

Ovine production may require importation into the future, and at present, the company definitely prefers NZ stocks.

Hopefully by then, economies of scale will be able to absorb the increased (?) costs of production.

As to output capacity however, that DOES need to be taken into account at some point.
Always handy to have as much information as we can get.

*I too am following and own a few PNV myself, as it can't hurt to have fingers in different pies, especially in these forms of biotech, and an ageing/type11 diabetic world, we will likely see.

Unfortunately though, the financials of PNV are both complex and unclear to my little brain ATM, but promise is definitely positive. All that is needed is more participation in this sector of the market, as liquidity is somewhat throttled in favour of techs and resources.

Cheers.